Combined therapy with mesenchymal stromal cells and vedolizumab contributes to deep remission in ulcerative colitis

Oleg Knyazev  1     Anna Kagramanova  1     Albina Lishchinskaya  1     Dmitriy Kulakov  1     Asfold Parfenov  2    
1 Loginov Moscow Clinical Scientific Centre,Moscow,Russian Federation
2 Loginov Moscow Clinical Scientific Centre,Moscow,Russian Fede

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing